KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Regeneron Pharmaceuticals (REGN) over the last 12 years, with Q4 2025 value amounting to $18.6 billion.

  • Regeneron Pharmaceuticals' Treasury Shares rose 2271.58% to $18.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.6 billion, marking a year-over-year increase of 2271.58%. This contributed to the annual value of $18.6 billion for FY2025, which is 2271.58% up from last year.
  • According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Treasury Shares is $33.7 million, which was up 1950.35% from $32.7 million recorded in Q3 2025.
  • Regeneron Pharmaceuticals' Treasury Shares' 5-year high stood at $33.7 million during Q4 2025, with a 5-year trough of -$17.1 million in Q1 2021.
  • Over the past 5 years, Regeneron Pharmaceuticals' median Treasury Shares value was $24.8 million (recorded in 2023), while the average stood at $21.1 million.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Treasury Shares surged by 54586.52% in 2021 and then surged by 1436.35% in 2024.
  • Over the past 5 years, Regeneron Pharmaceuticals' Treasury Shares (Quarter) stood at $8.3 billion in 2021, then grew by 25.33% to $10.4 billion in 2022, then rose by 21.32% to $12.6 billion in 2023, then increased by 20.76% to $15.2 billion in 2024, then increased by 22.72% to $18.6 billion in 2025.
  • Its Treasury Shares was $18.6 billion in Q4 2025, compared to $17.9 billion in Q3 2025 and $17.3 billion in Q2 2025.